Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.

Pharmacogenomics - 1 Dec 2011

Dandara Collet, Lombard Zané, Du Plooy Ingrid, McLellan Tracy, Norris Shane A, Ramsay Michèle

Abstract excerpt

AIM: The frequencies of variants of pharmacogenetic importance differ across populations. African populations exhibit the greatest genetic heterogeneity, cautioning against extrapolating results among African groups. The aim of this study was to genotype pharmacogenetically relevant variants in black South Africans, to expand the limited data set available for indigenous African populations. SUBJECTS & METHODS: A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily B
Share to Cytochrome P-450 CYP1A2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Nigeria

Share to Population

Share to South Africa

Share to Vitamin K Epoxide Reductases

Source

Identifiers

PMID: 22118051
DOI: 10.2217/pgs.11.106

Genes

ABCB1
VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.PMID 22118051Read ↗

Characterization of the genetic variation present in CYP3A4 in three South African populationsSemantic proximity Read ↗

Profiling of warfarin pharmacokinetics-associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics-dosing algorithm.Semantic proximity Read ↗

Cytochrome P450 pharmacogenetics in African populations.Semantic proximity Read ↗

Pharmacogenomics of warfarin in populations of A frican descentSemantic proximity Read ↗

CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global PharmacogeneticsSemantic proximity Read ↗

CYP2C gene polymorphisms in North African populations.Semantic proximity Read ↗

Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Analysis of pharmacogenetic traits in two distinct South African populations.Semantic proximity Read ↗

Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.Semantic proximity Read ↗

African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug DevelopmentSemantic proximity Read ↗

A Review of Clinical Pharmacogenetics Studies in African PopulationsSemantic proximity Read ↗

Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.